Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis
Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis
The Efficacy of Harpagophytum procumbens (Teltonal) in Patients with Knee Osteoarthritis: A Randomized Active-Controlled Clinical Trial
Evid Based Complement Alternat Med. 2021; 2021: 5596892.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty-eight patients with knee osteoarthritis were randomized to receive 1 month of Harpagophytum procumbens treatment (n=18) or 10 days of daily meloxicam (n=20). Outcomes of interest included pain on a Visual Analog Scale (VAS), the Oxford Knee Scale (OKS) score, and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) score. Outcomes were assessed at 2, 4 and 8 weeks follow up...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.